Considering the important role of MUC15/c-MET/PI3K/AKT/SOX2 axis in liver T-ICs, we believe that targeting the MUC15/c-MET/ PI3K/AKT/SOX2 axis could be a novel therapeutic strategy for HCC. This evidence concerns the gene SOX2 and hepatocellular carcinoma.